166 related articles for article (PubMed ID: 2976114)
1. Alternative pathway of complement.
Pangburn MK
Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
[No Abstract] [Full Text] [Related]
2. Purification and quantitation of the components of the alternative complement pathway.
Minta JO; Gee AP
Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
[No Abstract] [Full Text] [Related]
3. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
[No Abstract] [Full Text] [Related]
4. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
[TBL] [Abstract][Full Text] [Related]
5. [Alternative complement pathway].
Jouvin MH; Kazatchkine M
Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
[TBL] [Abstract][Full Text] [Related]
6. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.
Whaley K
J Exp Med; 1980 Mar; 151(3):501-16. PubMed ID: 6444659
[TBL] [Abstract][Full Text] [Related]
8. Activation of complement via the alternative pathway.
Pangburn MK
Fed Proc; 1983 Jan; 42(1):139-43. PubMed ID: 6217084
[TBL] [Abstract][Full Text] [Related]
9. [Compliment system proteins: properties and biological activity (Lecture)].
Kashkin KP; Dmitrieva LN
Klin Lab Diagn; 2000 Jul; (7):25-32. PubMed ID: 10981394
[No Abstract] [Full Text] [Related]
10. Alternative complement pathway activation by C4b deposited during classical pathway activation.
Matsushita M; Okada H
J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of C5 convertase of the alternative complement pathway with isolated C3b dimer and factors B and D.
Hong K; Kinoshita T; Pramoonjago P; Kim YU; Seya T; Inoue K
J Immunol; 1991 Mar; 146(6):1868-73. PubMed ID: 2005382
[TBL] [Abstract][Full Text] [Related]
12. Solubilization of immune precipitates by complement in the absence of properdin or factor D.
Späth PJ; Pascual M; Meyer-Hänni L; Schaad UB; Schifferli JA
FEBS Lett; 1988 Jul; 234(1):131-4. PubMed ID: 2968916
[TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative complement pathway.
Fearon DT
CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
[No Abstract] [Full Text] [Related]
14. Isolation of rabbit C3, Factor B, and Factor H and comparison of their properties with those of the human analog.
Horstmann RD; Müller-Eberhard HJ
J Immunol; 1985 Feb; 134(2):1094-100. PubMed ID: 3155535
[TBL] [Abstract][Full Text] [Related]
15. The alternative pathway of complement.
Pangburn MK; Müller-Eberhard HJ
Springer Semin Immunopathol; 1984; 7(2-3):163-92. PubMed ID: 6238433
[No Abstract] [Full Text] [Related]
16. Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors.
Seya T; Okada M; Hazeki K; Nagasawa S
Mol Immunol; 1991; 28(4-5):375-82. PubMed ID: 1829503
[TBL] [Abstract][Full Text] [Related]
17. The quest for an intrinsic C3 activating factor in human glomerular disease.
Roberts JL; Lewis EJ
Surv Immunol Res; 1982; 1(2):191-8. PubMed ID: 6227068
[No Abstract] [Full Text] [Related]
18. [Determination of the activity of the alternative pathway factor].
Nakanishi I; Inai S
Nihon Rinsho; 1979 Jun; Suppl():1451-3. PubMed ID: 490919
[No Abstract] [Full Text] [Related]
19. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
20. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Oct; 131(4):1930-5. PubMed ID: 6225800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
